This webinar builds on foundational amyloidosis imaging skills through a case-based exploration of advanced strain echocardiography, artificial intelligence, and the evolving role of ultrasound in clinical trials. As the therapeutic landscape for cardiac amyloidosis continues to expand, so does the sophistication required of diagnostic imaging. Clinical trials increasingly depend on precise, reproducible echo measures to track treatment response, and AI tools are rapidly moving from research curiosity to practical adjunct.

Using real-world cases, we will:

  • Dig into nuanced strain patterns, including borderline and discordant apical sparing presentations
  • Examine how AI-assisted analysis is beginning to support pattern recognition, quantification, and workflow efficiency in amyloidosis imaging
  • Explore how echocardiographic endpoints are being used in ongoing and emerging clinical trials for both ATTR and AL amyloidosis, and what that means for imagers working with trial-enrolled patients.

Faculty:

  • Sarah Cuddy, MD (Chair)
  • Akhil Narang MD, FASE
  • Jeremy Slivnick MD, FACC, FASE
  • Megan Kraushaar BS, RCS, FASE

CME Information: 1 AMA PRA Category 1 CreditTM   

Event Date

October 8, 2026 • 05:00 pm America/New_York

CME Credits

  • AMA PRA Category 1 Credit™

Delivery Method

  • Virtual

Contacts